TrialAnnals of the rheumatic diseases2013

Lupuzor/P140 peptide in patients with systemic lupus erythematosus: a randomised, double-blind, placebo-controlled phase IIb clinical trial.

Robert Zimmer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.